Evaluating Patient Preferences for Clinical Trial Endpoints in Early-Stage Cancer: A Discrete Choice Experiment in Canada.

Saved in:
Bibliographic Details
Title: Evaluating Patient Preferences for Clinical Trial Endpoints in Early-Stage Cancer: A Discrete Choice Experiment in Canada.
Authors: Mickle AT; Broadstreet HEOR, 177 W 7th Ave, Vancouver, BC V5Y 1L8, Canada., Simbulan F; AstraZeneca Canada Inc., 1004 Middlegate Rd, Mississauga, ON L4Y 1M4, Canada., Li B; AstraZeneca Canada Inc., 1004 Middlegate Rd, Mississauga, ON L4Y 1M4, Canada., Klein-Panneton K; AstraZeneca Canada Inc., 1004 Middlegate Rd, Mississauga, ON L4Y 1M4, Canada., Morrison CL; Broadstreet HEOR, 177 W 7th Ave, Vancouver, BC V5Y 1L8, Canada., Walker S; Broadstreet HEOR, 177 W 7th Ave, Vancouver, BC V5Y 1L8, Canada., Johnston KM; Broadstreet HEOR, 177 W 7th Ave, Vancouver, BC V5Y 1L8, Canada., Snow S; QEII Health Sciences Centre, Dalhousie University, 1796 Summer St, Halifax, NS B3H 3A7, Canada.
Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2026 May 26; Vol. 33 (6). Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1718-7729
DOI:10.3390/curroncol33060308